Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TP vs AC-T in HRD+ TNBC
NCT03876886Phase 3Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Feb 2019
- Primary completion
- Feb 2024
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in triple-negative breast cancer (TNBC), sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
carboplatin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT03876886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03876886.